Device Trial Radar · NCT06968741
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
May 19, 2025
Primary completion
Dec 2026
Study completion Dec 2031
Sponsor
- Lead sponsor
- UroMems SASNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 13, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, multicenter, single-arm study
Conditions
- Stress Urinary Incontinence (SUI)
Interventions
Artificial Urinary Sphincter (AUS)Device
AUS implant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Responder rate at 26 weeks post-activationTime frame: 26 weeks
Locations
19 sites in 2 countries. Site status is shown where the registry gives one.
University of California, Los Angeles
Los Angeles, California
University of California, San Francisco
San Francisco, California
Stanford University
Stanford, California
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.